167 related articles for article (PubMed ID: 35621672)
1. Successful Treatment with Selpercatinib for Ectopic Cushing's Syndrome Due to Medullary Thyroid Cancer.
Ragnarsson O; Piasecka M; Hallqvist A
Curr Oncol; 2022 May; 29(5):3494-3498. PubMed ID: 35621672
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Control of Hypercortisolism by Vandetanib in a Case of Medullary Thyroid Carcinoma with a Somatic RET Mutation.
Paepegaey AC; Cochand-Priollet B; Louiset E; Sarfati PO; Alifano M; Burnichon N; Bienvenu-Perrard M; Lahlou N; Bricaire L; Groussin L
Thyroid; 2017 Apr; 27(4):587-590. PubMed ID: 28068878
[TBL] [Abstract][Full Text] [Related]
3. Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature.
Corsello A; Ramunno V; Locantore P; Pacini G; Rossi ED; Torino F; Pontecorvi A; De Crea C; Paragliola RM; Raffaelli M; Corsello SM
Thyroid; 2022 Nov; 32(11):1281-1298. PubMed ID: 35833793
[No Abstract] [Full Text] [Related]
4. Case report of severe Cushing's syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception, and paraneoplastic dysautonomia: remission with sorafenib without reduction in cortisol concentration.
Hammami MM; Duaiji N; Mutairi G; Aklabi S; Qattan N; Abouzied Mel-D; Sous MW
BMC Cancer; 2015 Sep; 15():624. PubMed ID: 26354794
[TBL] [Abstract][Full Text] [Related]
5. Rapid and long-lasting response to selpercatinib of paraneoplastic Cushing's syndrome in medullary thyroid carcinoma.
Sitbon M; Chou P; Bengaly S; Poirot B; Laloi-Michelin M; Deville L; Pachev A; Kowo-Bille A; Dumont C; Chougnet CN
Eur Thyroid J; 2022 Dec; 11(6):. PubMed ID: 36069795
[TBL] [Abstract][Full Text] [Related]
6. Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma.
Baudry C; Paepegaey AC; Groussin L
N Engl J Med; 2013 Aug; 369(6):584-6. PubMed ID: 23924025
[No Abstract] [Full Text] [Related]
7. [Cushing's syndrome caused by paraneoplastic ACTH secretion 11 years after occurence of a medullary thyroid carcinoma].
von Mach MA; Kann P; Piepkorn B; Bruder S; Beyer J
Dtsch Med Wochenschr; 2002 Apr; 127(16):850-2. PubMed ID: 11961702
[TBL] [Abstract][Full Text] [Related]
8. A challenging case of ectopic ACTH-dependent Cushing's syndrome due to medullary thyroid carcinoma.
Komisarz-Calik M; Sarba P; Trofimiuk-Müldner M; Sokołowski G; Szpor J; Hubalewska-Dydejczyk A
Endokrynol Pol; 2024; 75(1):115-116. PubMed ID: 38497400
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
Jozaghi Y; Zafereo M; Williams MD; Gule-Monroe MK; Wang J; Grubbs EG; Vaporciyan A; Hu MI; Busaidy N; Dadu R; Waguespack SG; Subbiah V; Cabanillas M
Head Neck; 2021 Jan; 43(1):E7-E12. PubMed ID: 33169506
[TBL] [Abstract][Full Text] [Related]
10. Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.
Koehler VF; Fuss CT; Berr CM; Frank-Raue K; Raue F; Hoster E; Hepprich M; Christ E; Pusl T; Reincke M; Spitzweg C; Kroiss M;
Clin Endocrinol (Oxf); 2022 Jun; 96(6):847-856. PubMed ID: 34743368
[TBL] [Abstract][Full Text] [Related]
11. Medullary carcinoma of the thyroid as a cause of Cushing's syndrome: a case with ectopic adrenocorticotropin secretion characterized by double enzyme immunostaining.
Hijazi YM; Nieman LK; Medeiros LJ
Hum Pathol; 1992 May; 23(5):592-6. PubMed ID: 1568756
[TBL] [Abstract][Full Text] [Related]
12. Thyroid carcinoma and Cushing's syndrome. A report of two cases with a review of the common features of the "non-endocrine" tumours associated with Cushing's syndrome.
Williams ED; Morales AM; Horn RC
J Clin Pathol; 1968 Mar; 21(2):129-35. PubMed ID: 4301476
[TBL] [Abstract][Full Text] [Related]
13. [Cushing's syndrome caused by ectopic production of CRF by a medullary carcinoma of the thyroid body].
Tourniaire J; Rebattu B; Conte-Devolx B; Trouillas J; Grino M; Berger-Dutrieux N; Peix JL; Pugeat M
Ann Endocrinol (Paris); 1988; 49(1):61-7. PubMed ID: 3261569
[TBL] [Abstract][Full Text] [Related]
14. [Medullary carcinoma of the thyroid gland with Cushing's syndrome].
Zeman V; Nĕmec J
Cesk Patol; 1981 Aug; 17(3):129-32. PubMed ID: 7307141
[TBL] [Abstract][Full Text] [Related]
15. Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome.
Pitoia F; Bueno F; Schmidt A; Lucas S; Cross G
Arch Endocrinol Metab; 2015 Aug; 59(4):343-6. PubMed ID: 26331322
[TBL] [Abstract][Full Text] [Related]
16. Significant response of medullary thyroid cancer choroidal metastases to highly selective RET inhibitor selpercatinib: a case report.
Matrone A; Prete A; Sartini MS; Elisei R
Ann Oncol; 2021 Nov; 32(11):1447-1449. PubMed ID: 34419556
[No Abstract] [Full Text] [Related]
17. Ectopic Cushing's syndrome due to CRH secreting liver metastasis in a patient with medullary thyroid carcinoma.
Chrisoulidou A; Pazaitou-Panayiotou K; Georgiou E; Boudina M; Kontogeorgos G; Iakovou I; Efstratiou I; Patakiouta F; Vainas I
Hormones (Athens); 2008; 7(3):259-62. PubMed ID: 18694866
[TBL] [Abstract][Full Text] [Related]
18. Cushing's syndrome caused by ACTH- and calcitonin-secreting medullary carcinoma of the thyroid.
Melvin KE; Tashjian AH; Cassidy CE; Givens JR
Metabolism; 1970 Oct; 19(10):831-8. PubMed ID: 4319120
[No Abstract] [Full Text] [Related]
19. Pituitary ACTH dependent Cushing's syndrome due to ectopic production of a bombesin-like peptide by a medullary carcinoma of the thyroid.
Howlett TA; Price J; Hale AC; Doniach I; Rees LH; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1985 Jan; 22(1):91-101. PubMed ID: 2983908
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine carcinoma of the thyroid causing adrenocorticotrophic hormone-dependent Cushing's syndrome.
Dutta D; Mukhopadhyay S; Maisnam I; Ghosh S; Mukhopadhyay P; Chowdhury S
Thyroid; 2013 Jan; 23(1):120-3. PubMed ID: 23140512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
